PMID- 18579703 OWN - NLM STAT- MEDLINE DCOM- 20081027 LR - 20131121 IS - 1931-857X (Print) IS - 1522-1466 (Linking) VI - 295 IP - 3 DP - 2008 Sep TI - MCP-1/CCR2 system is involved in high glucose-induced fibronectin and type IV collagen expression in cultured mesangial cells. PG - F749-57 LID - 10.1152/ajprenal.00547.2007 [doi] AB - Monocyte chemoattractant protein-1 (MCP-1) is a potent chemokine that plays an important role in the recruitment of macrophages. Although previous studies have demonstrated the importance of MCP-1 in the pathogenesis of diabetic nephropathy (DN) in terms of inflammation, the role of MCP-1 and its receptor (C-C chemokine receptor 2; CCR2) in extracellular matrix (ECM) accumulation under diabetic conditions has been largely unexplored. This study was undertaken to investigate the functional role of the MCP-1/CCR2 system in high glucose-induced ECM (fibronectin and type IV collagen) protein expression in cultured mesangial cells (MCs). Mouse MCs were exposed to medium containing 5.6 mM glucose (NG), NG+24.4 mM mannitol (NG+M), or 30 mM glucose (HG) with or without mutant MCP-1 (mMCP-1), CCR2 small interfering (si)RNA, or CCR2 inhibitor (RS102895). To examine the relationship between MCP-1 and transforming growth factor (TGF)-beta1, MCs were also treated with TGF-beta1 (2 ng/ml) with or without mMCP-1 or CCR2 siRNA. Transient transfection was performed with Lipofectamine 2000 for 24 h. Cell viability was determined by an MTT assay, mouse and human MCP-1 and TGF-beta1 levels by ELISA, and CCR2 and ECM protein expression by Western blotting. Transfections of mMCP-1 and CCR2 siRNA increased human MCP-1 levels and inhibited CCR2 expression, respectively. HG-induced ECM protein expression and TGF-beta1 levels were significantly attenuated by mMCP-1, CCR2 siRNA, and RS102895 (P < 0.05). MCP-1 directly increased ECM protein expression, and this increase was inhibited by an anti-TGF-beta1 antibody. In addition, TGF-beta1-induced ECM protein expression was significantly abrogated by the inhibition of the MCP-1/CCR2 system (P < 0.05). These results suggest that an interaction between the MCP-1/CCR2 system and TGF-beta1 may contribute to ECM accumulation in DN. FAU - Park, Jehyun AU - Park J AD - Yonsei University College of Medicine, Department of Internal Medicine, 134 Shinchon-Dong, Seodaemoon-Gu, Seoul, Korea. FAU - Ryu, Dong-Ryeol AU - Ryu DR FAU - Li, Jin Ji AU - Li JJ FAU - Jung, Dong-Sub AU - Jung DS FAU - Kwak, Seung-Jae AU - Kwak SJ FAU - Lee, Sun Ha AU - Lee SH FAU - Yoo, Tae-Hyun AU - Yoo TH FAU - Han, Seung Hyeok AU - Han SH FAU - Lee, Jung Eun AU - Lee JE FAU - Kim, Dong Ki AU - Kim DK FAU - Moon, Sung Jin AU - Moon SJ FAU - Kim, Kunhong AU - Kim K FAU - Han, Dae Suk AU - Han DS FAU - Kang, Shin-Wook AU - Kang SW LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20080625 PL - United States TA - Am J Physiol Renal Physiol JT - American journal of physiology. Renal physiology JID - 100901990 RN - 0 (Ccl2 protein, mouse) RN - 0 (Ccr2 protein, mouse) RN - 0 (Chemokine CCL2) RN - 0 (Collagen Type IV) RN - 0 (Fibronectins) RN - 0 (RNA, Small Interfering) RN - 0 (Receptors, CCR2) RN - 0 (Transforming Growth Factor beta1) RN - IY9XDZ35W2 (Glucose) SB - IM MH - Animals MH - Cells, Cultured MH - Chemokine CCL2/genetics/*metabolism MH - Collagen Type IV/*metabolism MH - Diabetic Nephropathies/metabolism MH - Fibronectins/*metabolism MH - Glucose/metabolism MH - Humans MH - Mesangial Cells/*metabolism MH - Mice MH - Mice, Transgenic MH - Mutation MH - RNA, Small Interfering/genetics MH - Receptors, CCR2/genetics/*metabolism MH - Transfection MH - Transforming Growth Factor beta1/metabolism EDAT- 2008/06/27 09:00 MHDA- 2008/10/28 09:00 CRDT- 2008/06/27 09:00 PHST- 2008/06/27 09:00 [pubmed] PHST- 2008/10/28 09:00 [medline] PHST- 2008/06/27 09:00 [entrez] AID - 00547.2007 [pii] AID - 10.1152/ajprenal.00547.2007 [doi] PST - ppublish SO - Am J Physiol Renal Physiol. 2008 Sep;295(3):F749-57. doi: 10.1152/ajprenal.00547.2007. Epub 2008 Jun 25.